Prothena Corp Public (PRTA) Cash from Operations (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Cash from Operations came in at 28877000.0 in Q1 2026, up 154.11% year-on-year from 11363785.1 in Q1 2025, and up 223.87% quarter-over-quarter from 23312000.0 in Q4 2025.
Prothena Corp Public (PRTA) Cash from Operations (2012 - 2026) Analysis & Trends
Prothena Corp Public's Cash from Operations history runs 15 years deep, the most recent figure standing at 28877000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 154.11% year-over-year to 28877000.0 in Q1 2026; TTM through Mar 2026 was 81340000.0, a 37.6% increase from a year earlier, with the FY2025 full-year figure at 163580000.0, down 9.02% from the prior year.
- Cash from Operations improved to 28877000.0 in Q1 2026 per PRTA's latest filing, from 23312000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 28877000.0 in Q1 2026 and bottomed at 73051000.0 in Q1 2024.
- The 5-year median for Cash from Operations is 40565000.0 (2025), against an average of 31028235.29.
- Across the five-year window, Cash from Operations sank 925.68% in 2023 and surged 154.11% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 4976000.0 in 2022, then sank by 925.68% to 51038000.0 in 2023, then advanced by 6.4% to 47772000.0 in 2024, then jumped by 51.2% to 23312000.0 in 2025, then soared by 223.87% to 28877000.0 in 2026.
- Per Business Quant, the three latest PRTA Cash from Operations figures stand at 28877000.0 (Q1 2026), 23312000.0 (Q4 2025), and 40565000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 28.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.88 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Sep 30, 2025 | -40.57 Mn |
| Sep 30, 2025 | -40.57 Mn |
| Jun 30, 2025 | -46.34 Mn |
| Jun 30, 2025 | -46.34 Mn |
| Mar 31, 2025 | -53.36 Mn |
| Mar 31, 2025 | -53.36 Mn |
| Dec 31, 2024 | -47.77 Mn |
| Dec 31, 2024 | -47.77 Mn |
| Sep 30, 2024 | -45.19 Mn |
| Sep 30, 2024 | -45.19 Mn |
| Jun 30, 2024 | 15.96 Mn |
| Jun 30, 2024 | 15.96 Mn |
| Mar 31, 2024 | -73.05 Mn |
| Mar 31, 2024 | -73.05 Mn |
| Dec 31, 2023 | -51.04 Mn |
| Dec 31, 2023 | -51.04 Mn |